Our preliminary research work indicates that NDRG2 may regulate T-cell factor (TCF)/β-catenin signaling pathway, which lead to the inhibition of many target genes including C-MYC in human colon carcinoma (data not shown), and the related regulation mechanism is being investigated by our research group. The gene discussed is HNF4A; the disease is colon carcinoma.